Search

everythinglearnresearchcommunity

for

Search:↓

Proscar (finasteride) blocks 5α-reductase in sea urchin ovaries and testes, suggesting potential treatment for androgen-related conditions.

Spironolactone treatment reduced hair growth and androgen levels in hirsute women, but the overall effectiveness was just adequate.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Men with hair loss have lower SHBG and higher saliva testosterone levels, suggesting increased androgen activity.

Scopolin and scopoletin from Merremia peltata leaves may help treat hair loss and showed promising results in rabbit tests.

Men with liver cancer have higher levels of a specific testosterone byproduct in their liver and blood, despite overall lower male hormone levels.

Occipital hair follicles in male pattern baldness respond uniquely to testosterone, not androgen-insensitive.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

High androgen levels in young women with PCOS are linked to higher blood pressure.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Hidradenitis suppurativa improves with antiandrogen therapy.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Testosterone may influence COVID-19 severity and outcomes.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Low estrogen compared to androgen may cause female hair loss.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Men with low or no sperm count have lower salivary testosterone levels, and saliva testing can measure their testosterone well.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

Removing the ovarian tumor improved the woman's hormonal symptoms.

A 31-year-old woman was diagnosed with Complete Androgen Insensitivity Syndrome much later than usual, leading to a call for earlier detection and treatment guidelines.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.